Nine plaintiffs – six pharma companies and two alliances of industry groups – have sued the government over the price negotiation provisions of the Inflation Reduction Act (IRA), employing
The battle over drug pricing reforms in the US is heading for the courtroom as multiple pharma companies file legal challenges against the controversial Inflation Reduction Act.
CancerX, a new initiative under President Joe Biden’s Cancer Moonshot, looks to bring diverse stakeholders together to leverage digital technology to tackle the biggest challenges in cancer
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.